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Seasonality in depressive and anxiety symptoms
among primary care patients and in patients with
depressive and anxiety disorders; results from the
Netherlands Study of Depression and Anxiety
Wim H Winthorst1*, Wendy J Post2,3, Ybe Meesters1, Brenda WHJ Penninx1,4,5 and Willem A Nolen1
Abstract
Background: Little is known about seasonality of specific depressive symptoms and anxiety symptoms in different
patient populations. This study aims to assess seasonal variation of depressive and anxiety symptoms in a primary
care population and across participants who were classified in diagnostic groups 1) healthy controls 2) patients
with a major depressive disorder, 3) patients with any anxiety disorder and 4) patients with a major depression and
any anxiety disorder.
Methods: Data were used from the Netherlands Study of Depression and Anxiety (NESDA). First, in 5549 patients
from the NESDA primary care recruitment population the Kessler-10 screening questionnaire was used and data
were analyzed across season in a multilevel linear model. Second, in 1090 subjects classified into four groups
according to psychiatric status according to the Composite International Diagnostic Interview, overall depressive
symptoms and atypical versus melancholic features were assessed with the Inventory of Depressive Symptoms.
Anxiety and fear were assessed with the Beck Anxiety Inventory and the Fear questionnaire. Symptom levels across
season were analyzed in a linear regression model.
Results: In the primary care population the severity of depressive and anxiety symptoms did not show a seasonal
pattern. In the diagnostic groups healthy controls and patients with any anxiety disorder, but not patients with a
major depressive disorder, showed a small rise in depressive symptoms in winter. Atypical and melancholic
symptoms were both elevated in winter. No seasonal pattern for anxiety symptoms was found. There was a small
gender related seasonal effect for fear symptoms.
Conclusions: Seasonal differences in severity or type of depressive and anxiety symptoms, as measured with a
general screening instrument and symptom questionnaires, were absent or small in effect size in a primary care
population and in patient populations with a major depressive disorder and anxiety disorders.
Background
Epidemiological studies of seasonal variation in the pre-
valence of mental disorders have shown diverging
results. Seasonal variation in the prevalence of the major
mental disorders in general population surveys have
rarely been noted, but prevalence rates of mood
(affective) disorders with a seasonal pattern have been
reported to range from 1% to as much as 12% [1].
The majority of the latter studies reported on seasonal
affective disorder (SAD), defined in DSM IV as a recur-
rent depressive disorder with a regular temporal rela-
tionship between the onset of a major depressive
episode and a particular time of the year (mostly fall or
winter) and has used specific instruments for its assess-
ment [2,3]. The most widely used instrument in those
studies is the Seasonal Pattern Assessment Question-
naire (SPAQ), a self rating screening questionnaire that
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retrospectively measures seasonal variation in mood,
social activities and atypical depressive symptoms such
as increased sleep, increased appetite and weight and a
lowered energy level [4]. Female gender and young age
have been described to be associated with a higher pre-
valence of SAD [5,6]. The influence of latitude on the
prevalence of SAD has been suggested but could not be
demonstrated [7,8].
Absence of seasonal variation in the prevalence of
mental disorders has been reported in studies in which
data were collected using general structured interviews
or questionnaires on depression in different months of
the year. For example, in New England (USA) in a study
involving 1,500 patients of a psychiatric outpatient prac-
tice using the Structured Clinical Interview for DSM-IV
(SCID), there were no higher rates of onset of major
depressive disorders in spring and fall, and no higher
rates of atypical depression in the winter compared to
the other seasons [9]. In a multicenter study on the cur-
rent prevalence of depression in the United Kingdom,
Finland, Norway and Spain among 6608 participants
randomly identified via census registers or primary care
databases and using the Beck Depression Inventory
(BDI), also no evidence of a systematic seasonal pattern
in depression was found [10]. In Iceland no seasonal
mood change could be demonstrated in a cross sectional
study using the Hospital Anxiety and Depression Ques-
tionnaire in four 1000-person cohorts who received the
questionnaire in either January, April, July or October
[11]. Similarly, in a Dutch general population survey
among 7076 participants (NEMESIS), and using the
Composite International Diagnostic Interview (CIDI), no
seasonal difference was found in the 1-month prevalence
of the main categories of mood disorders or for the
broad category of anxiety disorders [12]. And finally, in
a UK study among 2,255 patients consulting their gen-
eral practitioner who were screened over the course of a
year using the General Health Questionnaire (GHQ 30),
no significant seasonal variation in GHQ scores was
found [13].
However, other studies also using general structured
interviews or questionnaires to assess depression did
report seasonal variations. In another Dutch general
population study among 5356 participants, a higher
mean score on the Centre for Epidemiological Studies
Depression Scale (CES-D) was found in the winter com-
pared to the summer [14]. In a general population study
in Norway among 11054 participants, modest variations
in the Hospital Anxiety and Depression Scale (HADS)
were found, mean sum scores being slightly higher dur-
ing November through March compared to the other
months [15]. In a US study among 1556 men and 314
women using the Hopkins Symptom Checklist, women
scored significantly higher in winter on the expanded
mood scale [16]. Finally, in the US National Comorbid-
ity Survey among 8,089 participants and using CIDI, a
lifetime prevalence of major depression with a seasonal
pattern of 0.4% was found, and a prevalence of major or
minor depression with a seasonal pattern of 1.0%[17].
In addition, the studies mentioned above did not mea-
sure seasonality in severity of atypical depressive symp-
toms, melancholic depressive symptoms and anxiety
symptoms in specific patient groups with depressive and
anxiety disorders.
The aim of this study was to determine if seasonal
variation exists in the severity and type of depressive
and anxiety symptoms in general and among patients
with a depressive or anxiety disorder. More specific
three questions were formulated: (1) Does a seasonal
pattern exist in the severity of depressive and anxiety
symptoms among patients visiting their general practi-
tioner for any reason?
(2) Does a seasonal pattern exist in the severity of
depressive or anxiety symptoms among patients with a
current depressive disorder, a current anxiety disorder, a
current depressive and anxiety disorder, and among
healthy controls; and is there a difference between these
groups?
(3) Does a seasonal pattern exist in type of depressive
symptoms (i.e. atypical or melancholic) among and
between these groups?
Methods
The study was conducted using data from the Nether-
lands Study of Depression and Anxiety (NESDA, http://
www.nesda.nl): (1) the NESDA primary care recruitment
population and (2&3) the NESDA baseline population
[18]. NESDA is an ongoing multi-site naturalistic 8-year
longitudinal cohort study among 2,981 adults (18-65
years), aimed at describing the long-term course and
consequences of depressive and anxiety disorders. The
NESDA sample (total n = 2981) is stratified for setting:
community, primary care and specialized mental health
care. The community sample (n = 564) was built on two
cohorts that were already available through prior studies
described in detail elsewhere [19]. The primary care par-
ticipants (n = 1610) were recruited among 23,750
patients from practices of 65 general practitioners (GPs)
in the vicinity of three research sites. The specialized
mental health patients (n = 807) were recruited from
outpatient clinics of regional facilities for mental health
care around the research sites.
Across recruitment settings, uniform inclusion and
exclusion criteria were used. The NESDA sample
included a range of psychopathology: those with no life-
time anxiety or depressive disorders (including healthy
controls), those with a current first or recurrent depres-
sive disorder (major depressive disorder or dysthymic
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disorder) or anxiety disorder (panic disorder with or
without agoraphobia, agoraphobia, social phobia or gen-
eralized anxiety disorders) and those with earlier epi-
sodes, or at risk because of sub threshold symptoms or
a positive parental history for depressive or anxiety dis-
orders. Excluded were patients with a psychotic disor-
der, bipolar disorder, obsessive compulsive disorder, or
severe substance use disorder, and persons not fluent in
Dutch.
Ethics Statement
The study protocol of NESDA was approved by the
Ethical Review Board of the VU University Medical
Center, the Leiden University Medical Center and the
University Medical Center Groningen. After full verbal
and written information about the study, written
informed consent was obtained from all participants at
the start of baseline assessment. A full ethics statement
of NESDA and detailed information on objectives and
methods of NESDA were published elsewhere [18].
Subjects
The NESDA primary care recruitment population, to
whom the Kessler-10 screening questionnaire was sent,
consisted of a random sample of all patients who had
visited their GP during the previous four months for
any reason from January 2004 to February 2007. The
date the questionnaire was filled out was recorded for
participants from the research sites in Amsterdam and
Groningen (latitude 52,3° and 53,2° respectively). Ques-
tionnaires with two or more answers missing were
excluded.
The NESDA baseline population comprised partici-
pants of the NESDA cohort who met the criteria of one
of four groups: 1) Healthy controls (HC), i.e. no lifetime
depressive or anxiety disorder; 2) Major depressive dis-
order (MDD) last month; 3) Any anxiety disorder
(AAD) last month; 4) Both major depressive disorder
and any anxiety disorder (MDD + AAD) last month.
Participants with a lifetime MDD or AAD but not
within the last month, and those not completing the self
report questionnaires (see below) within 7 days of the
baseline-interview, were left out of the analysis.
Measures
In the NESDA primary care recruitment population (n =
5,549) the Kessler-10 screening questionnaire (K-10) was
used. The K10 has proven screening qualities for affec-
tive disorders based on questions about anxiety and
depressive symptoms that a person has experienced in
the past 4 weeks [20,21].
In the NESDA baseline population (n = 1,090) the
CIDI (WHO version 2.1) was used to establish diagnoses
of MDD and AAD according to DSM-IV criteria
(American Psychiatric Association, 2001). Within 7 days
prior or after the CIDI interview, all participants com-
pleted several self-report questionnaires. Severity of
depression was assessed with the Inventory of Depres-
sive Symptoms, 30 item self-report versions (IDS) [22].
Moreover, the IDS was used to assess the presence and
severity of atypical and melancholic features, as the IDS
includes all symptoms of these specifiers. Therefore a
continuous atypical specifier was constructed (At-IDS):
a summation of the scores on the items mood reactivity,
the highest score of either weight gain or increase in
appetite, hypersomnia, leaden paralysis, and interperso-
nal rejection sensitivity (score range 0 - 3, total score
range 0 - 15). The scores of the item mood reactivity
were recoded (reversed) resulting in an item that counts
the presence of the symptom mood reactivity in stead of
its absence. Participants with one or more missing items
were excluded from the analysis. Also a continuous mel-
ancholic specifier was constructed (Mel-IDS): a summa-
tion of the scores on the items: loss of pleasure, lack of
reactivity to usually pleasurable stimuli, depressed
mood, regularly worse in the morning, early morning
awakening, psychomotor retardation or agitation, the
highest score of either anorexia or weight loss, and
excessive or inappropriate guilt (score range 0 - 3, total
score range 0 - 24). Also for Mel-IDS participants with
missing items were excluded from the analysis.
The Beck Anxiety Inventory (BAI), a 21-item self-
report instrument, was used to assess overall severity of
anxiety [23]. Finally the 15-item self-report version of
the Fear Questionnaire (FQ) was used to measure sever-
ity of fear and avoidance [24].
Statistical analysis
The dates were categorized into the four seasons
(spring: March 21 - June 20, summer: June 21 - Septem-
ber 20, autumn: September 21-December 20, winter:
December 21 - March 20). SPSS (SPSS 16.02 inc., 2008)
and MLwin (2.02) were used to analyze the data.
Descriptive analyses with means and standard errors for
quantitative data were calculated. 95% Confidence inter-
vals were calculated and a p-value smaller than 0.05
(two-sided) was considered to be significant.
Question 1. Seasonality in severity of depressive and
anxiety symptoms among primary care patients
(recruitment population)
As the distribution of the K-10 total score was skewed
and the assumption of normality was violated, the log
transformed K-10 score (LnK10) was calculated and
used as outcome variable. Taking into account the fact
that each GP had several participants, and assuming
that there could be dependency between participants
within the practices of the GPs, multilevel analysis (by
Winthorst et al. BMC Psychiatry 2011, 11:198
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MLwin) was used to analyze the course over time. In
this analysis the GP’s were considered to be on the
highest level, and participants on the lowest level. For
the quantitative outcome measure (LnK10), a linear
model was specified.
Analysis started with the empty model, a model only
including an intercept with random terms. In this
model, the different sources of variability (within GP’s
and between GP’s) were distinguished. Then, different
models for the time course were specified, based on the
four seasons, and different combinations of fixed and
random effects. Differences in deviance determined
whether the different specifications of the time course
were significant or not. Additionally, the predictors gen-
der, age, and the location of the field site were included
as fixed effects. Interaction terms were explored as well.
Question 2 & 3. Seasonality in severity of depressive and
anxiety symptoms and type of depressive symptoms in
patients with a current depressive and/or anxiety
disorder and in healthy controls
For all continuous outcome measures (IDS, At-IDS,
Mel-IDS, BAI and FQ), a linear regression model was
specified with group, season, age and gender as indepen-
dent variables. Only significant main effects were
included in the model. Analysis started with a model
only including the four groups of participants. Then, dif-
ferent models were specified with the four seasons, age
and gender as predictors. Based on literature and
descriptive statistics, two way interactions between sea-
son, gender, age and group were analyzed. Significant
interactions were additionally included in the model.
Standardized regression coefficients were calculated and
were used as a measure for the clinical relevance of the
findings.
Results
Question 1. Seasonality in severity of depressive and
anxiety symptoms among primary care patients
(recruitment population)
A total of 23,750 questionnaires was sent out. 10,706 K-
10 questionnaires were returned (45%). Those returning
the K-10 (10,706) were more likely to be women (59.3%
versus 50.0%, p < .001) and older (44.4 versus 39.0
years, p < .001) compared to those not returning the
screener. The date the K-10 was filled out could be
recovered for 5,563 participants from the field sites in
Amsterdam and Groningen. Because these dates were
not recorded in Leiden the participants from the field
site Leiden were excluded from the analysis. Off the
remainder 14 K-10 questionnaires had 2 or more
answers missing; and were excluded as a consequence.
The resuming 5,549 participants from 44 GPs were
included in the analysis, consisting of 3664 (66%)
women and 1885 (34%) men. The mean age was 43.6
years (SE = 0.17).
In Figure 1 the observed means and standard errors of
the K-10 score are presented per season. The observed
total mean K-10 score was 19.2 (SE = 0.11), the median
score was 17 (range 10-50), the lowest scores were
recorded in summer and the highest scores in autumn.
The mean score for women was higher than the mean
score for men. Older participants scored lower than
younger participants, with younger women scoring
higher than younger men. Amsterdam participants (n =
3392) scored higher than Groningen participants (n =
2157).
In table 1 the results of the multilevel regression ana-
lysis are presented for the log transformed K-10 scores.
The second model with the seasons as a predictor (with
spring as a reference), explains only little more variabil-
ity than the empty model as can be seen in the differ-
ence of the deviance (empty model 5086.6; model with
seasons 5085.6). In this second model the difference
between de seasons was not significant (summer -0.014,
SE 0.019; autumn -0.002, SE 0.021; winter -0.013, SE
0.021).
Adding the covariates gender, age and site the final
model showed that these variables contribute signifi-
cantly to the explanation of the model (gender 0.065, SE
0.011; age 0.002, SE 0.000; site -0.127, SE 0.019) but
there was no significant difference between the seasons
(summer -0.015, SE 0.018; autumn -0.022, SE 0.019;
winter -0.002, SE 0.019). No significant interactions
were found between the seasons and these covariates,
nor between the covariates themselves.
Back transformation of the log transformed K-10
scores revealed that women scored 1.07 higher than
men and participants in Amsterdam scored 1.15 higher
than participants in Groningen. On the highest level,
there was a significant difference of 1.01 points between
the GP’s.
Question 2 & 3. Seasonality in severity of depressive and
anxiety symptoms and type of depressive symptoms in
patients with a current depressive and/or anxiety
disorder and in healthy controls
Data comprised 1,090 participants (691 women = 63.4%)
of the NESDA cohort (2,981 participants) who met the
criteria of one of four groups and completed the IDS:
HC (n = 465), MDD (n = 131), AAD (n = 134), MDD +
AAD (n = 360). The BAI and the FQ had one partici-
pant missing, resulting in 1089 included participants. 16
Participants were excluded due to missing items on At-
IDS (1.5%) resulting in 1074 participants in the analysis
of At-IDS. 57 Participants were excluded due to missing
items on Me-IDS (5.2%) resulting in 1033 participants
in the analysis of Me-IDS.
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Figure 1 Kessler-10 screening Questionnaire: mean score per season. Primary care patients (n = 5549). Values are mean scores. Error bars
represent standard errors of the mean. Seasons: spring (March 21 - June 20), autumn (September 21-December 20), winter (December 21 -
March 20). There was no statistical difference between the seasons (defined as p < 0,05).
Table 1 Model of the log transformated scores of the Kessler-10 questionnaire
Empty model1 Seasons2 Full model3
Fixed Effect b (SE) b (SE) b (SE)
Intercept 2.887 (0.013) 2.863 (0.024) 2.984 (0.025)
Spring (reference)
Summer -0.014 (0.019) -0.015 (0.018)
Autumn -0.002 (0.021) 0.022 (0.019)







Level two: General practitioner Intercept variance 0.007 (0.002) 0.007 (0.002) 0.002 (0.001)*
Level one: Individual variance 0.144 (0.003) 0.144 (0.003) 0.142 (0.003)
Deviance 5086.6 5085.6 4928.3
b = Beta
SE = standard error
* p < 0.05
1) Empty model
2) Model with seasons
3) Full model with seasons and covariates
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2.1. Severity of depressive symptoms
Figure 2 presents the observed means and standard
errors of the IDS by season for the four groups. The
observed mean score was lowest for autumn (20.9, SE
0.90) and highest for winter (25.7, SE 1.00), with inter-
mediate scores for spring (22.0, SE 1.01) and summer
(21.7, SE 1.01). As expected, the observed mean score
increased with the severity of the pathology: HC scored
8.2 (SE 0.34), patients with AAD 20.7 (SE 0.83), patients
with MDD 32.1 (SE 0.93) and patients with MDD +
AAD 38.0 (SE 0.57). Taking all seasons together, the
observed mean score for men was 21.2 (SE 0.83) and for
women 23.2 (SE 0.61).
In tables 2 and 3 the results of the regression analysis
are presented. In the model with only groups as predic-
tor, the difference between the groups was significant
with a medium to large effect size. In the second model
with the seasons as predictor there were no significant
differences between the seasons. Adding the predictors
gender and age revealed that women scored significantly
higher than men but there was no significant age effect.
In this model with seasons and covariates there was no
significant difference between the seasons. In the full
model with seasons, covariates and interactions there
were significant two way interactions between gender
and season, meaning that the difference in score
between men and women varied per season. Women
scored higher than men in spring and summer (+1.0,
+4.7 resp.), the difference diminishing in autumn (+ 0.2)
and reversing in winter with women scoring lower than
men (-0.6). There was also a significant two way interac-
tion between group and season: the difference between
winter and summer was 3.7 points smaller for MDD
patients (+2.6) than for the other groups (+6.3). There
was no significant main effect of age, nor were there any
significant two way interactions between age and group,
age and season, age and gender, and gender and group.
In the final model the effect size was large for the
groups but small for the seasons and interactions terms
as can be seen from the unstandardized and standar-
dized regression coefficients.
2.2 Severity of anxiety symptoms (BAI)
The observed mean score was lowest for autumn (12.3
SE 0.69) and highest for winter (13.9 SE 0.70). The
observed mean score for men was 11.9 (SE 0.59) and for
Figure 2 Inventory of Depressive Symptoms*: mean score per season. *30 Item self-report version of the Inventory of Depressive
Symptoms. Total group (n = 1090), ▬ = Healthy Control (n = 465), ▲ = Any Anxiety disorder last month (n = 134), ■ = Major Depression last
month (n = 131), ● = Major Depression and Any Anxiety Disorder last month (n = 360). Values are mean scores. Error bars represent Standard
Errors of the mean.
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women 13.6 (SE 0.46). The observed mean score for HC
was 3.9 (SE 0.23), for patients with AAD 15.8 (SE 0.88),
for patients with MDD 14.9 (SE 0.90) and for patients
with MDD + AAD 13.0 (SE 0.36). In Figure 3 the
observed means and standard errors of the BAI are pre-
sented by season for the four groups.
In tables 4 and 5 the results of the regression analysis
are presented. In the model with only groups as predic-
tor, the difference between the groups was significant
with a medium to large effect size. In the second model
with the seasons as predictor there were no significant
differences between the seasons. Adding the predictors
gender and age revealed that women scored significantly
higher than men but there was no significant age effect.
In this model with seasons and covariates there was still
no significant difference between the seasons. In the full
model with seasons, covariates and interactions there
were significant two way interactions between season
and group: Patients with a MDD scored lower in winter
compared to summer (-2.9) and patients with MDD +
AAD scored lower in spring compared to the summer
(-2.9). There were significant main effects for the
groups: patients with MDD and AAD scored higher
than HC (+ 11.8). This was reduced in winter for
patients with MDD (+ 8.9). Patients with MDD + AAD
scored higher than HC (+20.2) which was reduced in
winter (+ 17.3). There was a significant main effect for
gender; women scored higher than men (+1.2). There
was no significant main effect of age and there were no
significant two way interactions between age and gender,
age and season, age and group, gender and group or
season and gender. In the final model the effect size was
large for the groups but small for the seasons and inter-
actions terms as can be seen from the unstandardized
and standardized regression coefficients.
2.3 Severity of anxiety symptoms (FQ)
The observed mean score was low for autumn (22.9 SE
1.2) and spring (23.9 SE 1.20), and high for summer
(26.4 SE 1.35) and winter (27.0 SE 1, 23). The observed
mean score for men was 21.9 (SE 0.97) and for women
26.7 (SE 0.81). In Figure 4 the observed means and stan-
dard errors of the FQ are presented by season for the
four groups.
In tables 6 and 7 the results of the regression analysis
are presented. In the model with only groups as predic-
tor, the difference between the groups was significant
with a small to large effect size. In the second model
with the seasons as predictor there were no significant
differences between the seasons. Adding the predictors
gender and age revealed that women scored significantly
higher than men but there was no significant age effect.
In this model with seasons and covariates there was still
no significant difference between the seasons. In the full
model with seasons, covariates and interactions there
were significant two way interactions between season
and gender with women scoring higher in summer and
autumn compared tot men (+7.1). The difference
Table 2 IDS total score: regression model with groups and model with seasons
Main Effects B SE LB UB b p B SE LB UB b p
Intercept 8.24 0.43 7.40 9.08 < 0.01* 7.90 0.66 6.60 9.20 < 0.01*
HC (reference)
MDD 23.86 0.92 22.06 25.66 .73 < 0.01* 23.74 0.92 21.94 25.55 .73 < 0.01*
AAD 12.45 0.91 10.67 14.23 .38 < 0.01* 12.34 0.91 10.55 14.14 .38 < 0.01*
MDD + AAD -6.55 1.31 -9.12 -3.98 -.19 < 0.01* -6.41 1.32 -8.99 -3.83 -.19 < 0.01*
Summer (reference)
Autumn 0.14 0.77 -1.38 1.65 .00 0.86
Winter 1.09 0.82 -0.53 2.70 .03 0.19
Spring 0.46 0.82 - 1.16 2.07 .01 0.58
IDS = Inventory of Depressive Symptoms
B = Unstandardized Coefficient
SE = standard error of B
LB = Lower Bound of 95% Confidence Interval for B
UB = Upper Bound of 95% Confidence Interval for B
b = Standardized Coefficient
* p < 0.05
HC = Healthy Control
MDD = Major Depressive Disorder
AAD = Any Anxiety Disorder
MDD + AAD = Major Depressive Disorder + Any Anxiety Disorder
Note: adjusted R2 Model with groups = 0,675
Note: adjusted R2 Model with seasons = 0,674
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between women and men was levelled in spring and
marginal in winter (+1). There were significant main
effects for the groups: patients with MDD scored 12
points higher than HC, patients with AAD scored 17.1
points higher than HC and patients with MDD an AAD
scored 27.4 points higher than HC. There was no signif-
icant main effect of age and there were no significant
two way interactions between age and gender, age and
season, age and group, gender and group or season and
group. In the final model the effect size was medium for
the groups but small for the seasons and interactions
terms as can be seen from the unstandardized and stan-
dardized regression coefficients.
3.1. Atypical depressive symptoms
In Figure 5 the observed means and standard errors of
the atypical symptoms are presented by season for the
four groups. The observed mean score was lowest for
autumn (5.4, SE 0.13) and highest for winter (6.1 SE
0.15), with intermediate scores for spring (5.6 SE 0.14)
and summer (5.5 SE .15). The observed mean score for
HC was 4.3 (SE 0.07), for patients with AAD 5.5 (SE
0.16), for patients with MDD 6.5 (SE 0.20) and for
patients with MDD + AAD 7.2 (SE 0.12). Taking all sea-
sons into account, the observed mean score for men was
5.2 (SE 0.11) and 5.9 (SE 0.09) for women.
In tables 8 and 9 the results of the regression analysis
are presented. In the model with only groups as predic-
tor, the difference between the groups was significant
with a small to large effect size. In the second model
with the seasons as predictor there were no significant
differences between the seasons. Adding the predictors
gender and age revealed that women scored significantly
higher than men and younger participants scored signifi-
cantly higher than older participants. In this model with
seasons and covariates there was no significant differ-
ence between the seasons. In the full model with sea-
sons, covariates and interactions there were significant
two way interactions between gender and season and
between gender and age. Women scored lower in
Table 3 IDS total score: regression model with groups, seasons, covariates and full model with interactions
Main Effects B SE LB UB b p B SE LB UB b p
Intercept 5.83 1.18 3.50 8.15 < 0.01* 4.60 1.00 2.64 6.56 < 0.01*
HC (reference)
MDD 23.75 0.92 21.95 25.55 .72 < 0.01* 24.80 0.97 22.90 26.69 .76 < 0.01*
AAD 12.37 0.91 10.58 14.16 .38 < 0.01* 12.36 0.91 10.58 14.15 .38 < 0.01*
MDD + AAD -6.51 1.31 -9.09 -3.94 -.19 < 0.01* -6.63 1.31 -9.19 -4.06 -.19 < 0.01*
Summer (reference)
Autumn 0.12 0.77 -1.40 1.63 .00 0.88 2.94 1.25 0.48 5.39 .08 0.02*
Winter 1.08 0.82 -0.53 2.70 .03 0.19 6.28 1.50 3.35 9.21 .16 < 0.01*
Spring 0.45 0.82 -1.16 2.07 .01 0.59 2.72 1.37 0.04 5.40 .07 0.05*
Men (reference)
Women 1.36 0.58 0.21 2.50 .40 0.002* 4.70 1.18 2.38 7.02 .14 < 0.01*
Age 0.03 0.02 -0.01 0.07 .02 0.16
Two way interactions
Winter & MDD -3.74 1.33 -6.35 -1.13 .08 < 0.01*
Autumn & Women -4.53 1.58 -7.64 -1.43 -.11 < 0.01*
Winter & Women -5.34 1.68 -8.63 -2.04 -.12 < 0.01*
Spring & Women -3.72 1.70 -7.07 -0.38 -.08 0.03*
IDS = Inventory of depressive Symptoms
B = Unstandardized Coefficient
SE = standard error of B
LB = Lower Bound of 95% Confidence Interval for B
UB = Upper Bound of 95% Confidence Interval for B
b = Standardized Coefficient
* p < 0.05
HC = Healthy Control
MDD = Major Depressive Disorder
AAD = Any Anxiety Disorder
MDD + AAD = Major Depressive Disorder + Any Anxiety Disorder
Note: adjusted R2 Model with seasons and covariates = 0,675
Note: adjusted R2 Full model with seasons, covariates and interactions = 0,680
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Figure 3 Becks Anxiety Inventory*: mean score per season. *21-item self-report version. Total group (n = 1089), ▬ = Healthy Control (n =
465), ▲ = Any Anxiety disorder last month (n = 133), ■ = Major Depression last month (n = 131), ● = Major Depression and Any Anxiety
Disorder last month (n = 360). Values are mean scores. Error bars are Standard Errors of the mean.
Table 4 Becks Anxiety Inventory: regression model with groups and model with seasons
Main Effects B SE LB UB b p B SE LB UB b p
Intercept 3.94 0.40 3.15 4.72 < 0.01* 3.84 0.62 2.63 5.05 < 0.01*
HC (reference)
MDD 10.92 0.85 9.24 12.60 .46 < 0.01* 11.02 0.86 9.34 12.71 .46 < 0.01*
AAD 11.91 0.85 10.24 13.57 .50 < 0.01* 12.01 0.86 10.33 13.69 .50 < 0.01*
MDD + AAD -3.93 1.22 -6.33 -1.53 -.16 < 0.01* -4.05 1.23 -6.47 -1.64 -.16 < 0.01*
Summer (reference)
Autumn 0.36 0.72 -1.05 1.78 .01 0.61
Winter -0.54 0.77 -2.05 0.97 .02 0.48
Spring 0.26 0.77 -1.24 1.77 .009 0.73
B = Unstandardized Coefficient
SE = standard error of B
LB = Lower Bound of 95% Confidence Interval for B
UB = Upper Bound of 95% Confidence Interval for B
b = Standardized Coefficient
* p < 0.05
HC = Healthy Control
MDD = Major Depressive Disorder
AAD = Any Anxiety Disorder
MDD + AAD = Major Depressive Disorder + Any Anxiety Disorder
Note: adjusted R2 Model with groups = 0,478
Note: adjusted R2 Model with seasons = 0,477
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autumn compared to summer (-0.7) and for every addi-
tional year of age women scored lower (-0.02), resulting
in a 0.9 points diminished score for a 65 year old
woman and a 0.5 points diminished score for a 43-year
old woman compared to 18-year old woman. There was
a significant main effect for the winter compared to
summer (+0.3). There were significant main effects for
the groups: patients with AAD, MMD and MMD +
AAD scored higher than HC (resp. + 1.2, + 2.3, + 2.9).
There were no significant two way interactions between
age and season, age and group, gender and group or
season and group. In the final model the effect size was
medium to large for the groups but small for the sea-
sons and interactions terms as can be seen from the
unstandardized and standardized regression coefficients.
3.2 Melancholic depressive symptoms
The observed mean score was lowest for summer and
autumn (5.0, SE 0.29) and highest for winter (6.0 SE
0.31). The observed mean score for both men and
women was 5.3 (SE resp. 0.26 and 0.18). The observed
mean score for HC was 1.6 (SE 0.10), for patients with
AAD 4.5 (SE 0.30), for patients with MDD 8.2 (SE 0.36)
and for patients with MDD + AAD 9.4 (SE 0.20). In Fig-
ure 6 the observed means and standard errors of the
atypical symptoms are presented by season for the four
groups.
In tables 10 and 11 the results of the regression analy-
sis are presented. In the model with only groups as pre-
dictor, the difference between the groups was significant
with a medium to large effect size. In the second model
with the seasons as predictor there were no significant
differences between the seasons. Adding the predictors
gender and age revealed that there was no significant
effect for gender or age. In this model with seasons and
covariates there was still no significant difference
between the seasons. In the full model with seasons,
covariates and interactions there was a significant two
way interaction between gender and group: women with
a MDD scored lower than men with MDD (-1.1)
whereas there was no difference in score between men
and women for the other groups. There was also a sig-
nificant two way interaction between season and group:
patients with MDD scored lower in winter (-0.4) com-
pared to the summer whereas the other groups scored
higher in winter compared to summer (+0.7). There
were significant main effects for the groups: patients
with AAD scored higher than HC (+2.9) and patients
with MDD + AAD scored 8.8 points higher than HC.
Taking the interactions mentioned into account, men
Table 5 Becks Anxiety Inventory: regression model with groups, seasons, covariates and full model with interactions
Main Effects B SE LB UB b p B SE LB UB b p
Intercept 3.09 0.70 1.71 4.46 < 0.01* 2.62 0.72 1.21 4.03 < 0.01*
HC (reference)
MDD 11.07 0.86 9.39 12.75 .46 < 0.01* 11.81 0.91 10.03 13.60 .49 < 0.01*
AAD 12.02 0.85 10.35 13.70 .50 < 0.01* 11.83 0.85 10.15 13.51 .49 < 0.01*
MDD + AAD -4.16 1.23 -6.57 -1.76 -.16 < 0.01* -3.43 1.27 -5.91 -0.95 -.14 < 0.01*
Summer (reference)
Autumn 0.34 0.72 -1.07 1.75 .01 0.64 0.35 0.72 -1.06 1.76 .01 0.63
Winter -0.55 0.77 -2.05 0.96 .02 0.48 0.92 1.01 -1.05 2.89 .03 0.36
Spring 0.20 0.77 -1.30 1.71 .007 0.27 1.13 0.88 -0.60 2.86 .04 0.20
Men (reference)
Women 1.24 0.54 0.17 2.31 .05 0.02* 1.23 0.54 0.16 2.29 .05 0.02*
Two way interactions
Winter & MDD -2.93 1.28 -5.44 -0.42 -.08 0.02*
Spring & MDD + AAD -2.86 1.37 -5.53 -0.18 -.06 0.04*
B = Unstandardized Coefficient
SE = standard error of B
LB = Lower Bound of 95% Confidence Interval for B
UB = Upper Bound of 95% Confidence Interval for B
b = Standardized Coefficient
* p < 0.05
HC = Healthy Control
MDD = Major Depressive Disorder
AAD = Any Anxiety Disorder
MDD + AAD = Major Depressive Disorder + Any Anxiety Disorder
Note: adjusted R2 Model with seasons and covariates = 0,480
Note: adjusted R2 Full model with seasons, covariates and interactions = 0,482
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Figure 4 Fear Questionnaire*: mean score per season. * 15 item self report version. Total group (n = 1089), ▬ = Healthy Control (n = 465), ▲
= Any Anxiety disorder last month (n = 133), ■ = Major Depression last month (n = 131), ● = Major Depression and Any Anxiety Disorder last
month (n = 360). Values are mean scores. Error bars are Standard Errors of the mean.
Table 6 Fear Questionnaire: regression model with groups and model with seasons
Main Effects B SE LB UB b p B SE LB UB b p
Intercept 12.29 0.78 10.76 13.83 < 0.01* 13.91 1.21 11.54 16.28 < 0.01*
HC (reference)
MDD 11.82 1.67 8.55 15.10 .28 < 0.01* 11.81 1.68 8.52 15.10 .28 < 0.01*
AAD 17.02 1.66 13.77 20.28 .41 < 0.01* 16.96 1.67 13.68 20.24 .41 < 0.01*
MDD + AAD -1.27 2.39 -5.96 3.43 -.03 0.60 -1.23 2.40 -5.94 3.48 -.03 0.61
Summer (reference)
Autumn -2.18 1.41 -4.95 0.58 .05 0.12
Winter -1.62 1.50 -4.57 1.33 .03 0.28
Spring -2.43 1.50 -5.38 0.51 .05 0.11
B = Unstandardized Coefficient
SE = standard error of B
LB = Lower Bound of 95% Confidence Interval for B
UB = Upper Bound of 95% Confidence Interval for B
b = Standardized Coefficient
* p < 0.05
HC = Healthy Control
MDD = Major Depressive Disorder
AAD = Any Anxiety Disorder
MDD + AAD = Major Depressive Disorder + Any Anxiety Disorder
Note: adjusted R2 Model with groups = 0,335
Note: adjusted R2 Model with seasons = 0,336
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with MDD scored higher than HC (+7.5); this was
reduced to +6.6 points for women (-0.9) and to +5.5
(-1.1) points for women in winter. There was no signifi-
cant main effect of age and there were no significant
two way interactions between season and gender, age
and gender, age and season, age and group. In the final
model the effect size was medium to large for the
groups but small for the seasons and interactions terms
as can be seen from the unstandardized and standar-
dized regression coefficients.
Discussion
The main findings of this study can be summarized as
follows. 1) Using a general screening questionnaire, no
seasonal pattern in the severity of depressive and anxiety
symptoms among primary care patients visiting their
general practitioner for any reason could be demon-
strated. 2) Among the four diagnostic groups of the
NESDA baseline population a small rise of depressive
symptoms was found in winter for healthy controls and
for patients with any anxiety disorder but neither for
patients with a major depression nor for patients with a
major depression and an anxiety disorder. Statistical sig-
nificant differences between the seasons were accompa-
nied by small effect sizes. 3) Both atypical and
melancholic symptoms were slightly higher in winter. A
distinguishing seasonal pattern in type of (i.e. atypical or
melancholic) depressive symptoms could not be demon-
strated. For anxiety symptoms (BAI) no seasonal effect
could be demonstrated. For symptoms of fear and
avoidance (FQ) a small gender related seasonal effect
was found with more complaints among women in sum-
mer and autumn.
The finding of no seasonal pattern in the severity of
depressive and anxiety symptoms in a primary care
population (question 1) contrasts to the findings of
Mersch et al. [14] who did find seasonality in depressive
symptoms as measured with the CES-D scores, and with
Oyane et al. [15] who found modest seasonal variations
in the depression scores on the Hospital Anxiety and
Depression Scale (HADS), both in samples of the gen-
eral population. These opposing findings might be
explained by differences in the populations under scru-
tiny: general population versus primary care population
which could reflect a source of selection bias indepen-
dent of season. However the results of our study are in
line with studies in the general population that failed to
demonstrate seasonal fluctuation in the prevalence of
depression using general diagnostic instruments like the
BDI and the CIDI [10,12]. The results of our study are
Table 7 Fear Questionnaire: regression model with groups, seasons, covariates and full model with interactions
Main Effects B SE LB UB b p B SE LB UB b p
Intercept 11.42 1.36 8.75 14.10 < 0.01* 9.56 1.48 1.21 6.65 < 0.01*
HC (reference)
MDD 11.97 1.67 8.70 15.24 .29 < 0.01* 11.98 1.67 10.03 8.72 .29 < 0.01*
AAD 17.01 1.66 13.75 20.26 .41 < 0.01* 17.07 1.66 10.15 13.82 .41 < 0.01*
MDD + AAD -1.60 2.39 -6.28 3.09 -.04 0.51 -1.68 2.38 -5.91 -6.36 -.04 < 0.48
Summer (reference)
Autumn -2.26 1.40 -5.01 0.49 -.05 0.11 -2.31 1.40 -1.06 -5.05 .05 0.09
Winter -1.63 1.49 -4.56 1.29 .03 0.27 2.17 2.19 -1.05 -2.13 .04 0.32
Spring -2.63 1.49 -5.56 0.30 .05 0.78 1.91 2.28 -0.60 -2.56 .04 0.40
Men (reference)
Women 4.09 1.06 2.01 6.16 .10 < 0.01* 7.10 1.43 0.16 4.29 .17 < 0.01*
Two way interactions
Spring & Women -7.05 2.60 -5.44 -11.24 -.10 0.02*
Winter & Women -6.14 2.65 -5.53 -12.25 -.12 < 0.01*
B = Unstandardized Coefficient
SE = standard error of B
LB = Lower Bound of 95% Confidence Interval for B
UB = Upper Bound of 95% Confidence Interval for B
b = Standardized Coefficient
* p < 0.05
HC = Healthy Control
MDD = Major Depressive Disorder
AAD = Any Anxiety Disorder
MDD + AAD = Major Depressive Disorder + Any Anxiety Disorder
Note: adjusted R2 Model with seasons and covariates = 0,344
Note: adjusted R2 Full model with seasons, covariates and interactions = 0,349
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Figure 5 Inventory of Depressive Symptoms*, Atypical symptoms#: mean score per season. * 30 Item self-report version of the Inventory
of Depressive Symptoms. # Atypical symptoms: summation of the scores on 5 items: mood reactivity, the highest score of either weight gain or
increase in appetite, hypersomnia, leaden paralysis, and interpersonal rejection sensitivity (score range 0 - 3, total score range 0 - 15). Total group
(n = 1074), ▬ = Healthy Control (n = 446), ▲ = Any Anxiety disorder last month (n = 129), ■ = Major Depression last month (n = 121), ● = Major
Depression and Any Anxiety Disorder last month (n = 337). Values are mean scores. Error bars are Standard Errors of the mean.
Table 8 Atypical symptoms of the IDS: regression model with groups and model with seasons
Main Effects B SE LB UB b p B SE LB UB b p
Intercept 4.26 0.09 4.08 4.43 < 0.01* 4.16 0.14 3.89 4.43 < 0.01*
HC (reference)
MDD 2.24 0.19 1.87 2.62 .48 < 0.01* 2.21 0.19 1.83 2.59 .48 < 0.01*
AAD 1.23 0.19 0.86 1.60 .26 < 0.01* 1.19 0.19 0.82 1.57 .26 < 0.01*
MDD + AAD -0.56 0.27 -1.10 -0.02 -.11 0.04* -0.51 0.28 -1.10 0.03 -.10 0.06
Summer (reference)
Autumn 0.02 0.16 -0.30 0.34 .004 0.90
Winter 0.34 0.17 -0.001 0.67 .06 0.51
Spring 0.13 0.17 -0.21 0.47 .02 0.45
IDS = Inventory of Depressive symptoms
B = Unstandardized Coefficient
SE = standard error of B
LB = Lower Bound of 95% Confidence Interval for B
UB = Upper Bound of 95% Confidence Interval for B
b = Standardized Coefficient
* p < 0.05
HC = Healthy Control
MDD = Major Depressive Disorder
AAD = Any Anxiety Disorder
MDD + AAD = Major Depressive Disorder + Any Anxiety Disorder
Note: adjusted R2 Model with groups = 0,312
Note: adjusted R2 Model with seasons = 0,314
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also supported by Magnusson et al. [11] who reported
on the lack of seasonality in anxiety and depression,
measured with the HADS, in the Icelandic population
and by Blacker et al. [13], who found no significant sea-
sonal variation in General Health Questionnaire scores
in a primary care population. A second explanation may
be found in the difference in data collection. In the stu-
dies by Mersch et al. [14], and Oyane et al. [15] season-
ality was assessed retrospectively using questionnaires
that assessed fluctuations of symptoms over the year.
Like Nayar and Cochrane [25] we think that due to
recall bias the retrospective data collection might lead to
an overestimation of the seasonal fluctuation in severity
and prevalence of affective symptoms. In this study, as
in the study by Blacker et al. [13], seasonality was
assessed using data on presence and severity of symp-
toms collected in a cross-sectional way over the year.
The cross sectional method of sampling in our study
might have introduced a source of selection bias with
different groups of patients in different seasons. A third
explanation might be that the percentage of patients
with a specific seasonal pattern of their complaints in a
random population of patients visiting their general
practitioner is too small (ranging from 0.4 - 5.6%) to
have an effect on the mean scores of depression or anxi-
ety symptoms in that population, even if the severity of
their complaints and the health service use of these
patients is increased in the winter [26]. For example Bla-
zer et al. [17] found a prevalence of 0,4% of major
depression with a seasonal pattern and 1% of major or
minor depression with a seasonal pattern in a commu-
nity based sample, Levitt et al. [27] found a prevalence
of 2,9% of seasonal affective disorder in a community
sample, Eagles et. al. [6] found a prevalence of 5.3% of
seasonal affective disorder during the winter months in
a primary care population and Thompson et al. [1]
found a prevalence of 5.6% of seasonal affective disor-
ders in a primary care population.
The finding of minimal seasonal differences in severity
of depressive or anxiety symptoms (question 2) in var-
ious clinical groups is in agreement with the study of
Posternak and Zimmerman [9], who did not find higher
rates of depressive symptoms in winter in an out-patient
population. Seasonal fluctuation of depressive symptoms
Table 9 Atypical symptoms of the IDS: regression model with groups, seasons, covariates and full model with
interactions
B SE LB UB b p B SE LB UB b p
Intercept 4.27 0.24 3.79 4.74 < 0.01* 3.64 0.34 2.97 4.31 < 0.01*
HC (reference)
MDD 2.26 0.19 1.88 2.63 .48 < 0.01* 2.25 0.19 1.88 2.62 .48 < 0.01*
AAD 1.19 0.19 0.82 1.56 .26 < 0.01* 1.20 0.19 0.83 1.56 .26 < 0.01*
MDD + AAD -0.58 0.27 -1.10 -0.05 -.12 0.03* -0.57 0.27 -1.10 -0.04 -.12 0.04*
Summer (reference)
Autumn 0.003 0.16 -0.31 0.32 .001 0.98 0.44 0.23 -0.01 0.89 .09 0.54
Winter 0.33 0.17 0.002 0.67 .06 < 0.05* 0.34 0.17 0.01 0.67 .06 < 0.05*
Spring 0.07 0.17 -0.26 0.40 .01 0.67 0.06 0.17 -0.27 0.39 .01 0.73
Men (reference)
Women 0.65 0.12 0.42 0.89 .14 < 0.01* 1.71 0.40 0.92 2.50 .36 < 0.01*
Age -0.01 0.004 -0.02 0.03 -.07 < 0.01* 0.00 0.01 -0.01 0.01 .002 0.95
Two way interactions
Autumn & Women -0.73 0.26 -1.25 -0.22 -.13 < 0.01*
Age & Women -0.02 0.009 -0.037 -0.002 -.19 0.03*
IDS = Inventory of Depressive Symptoms
B = Unstandardized Coefficient
SE = standard error of B
LB = Lower Bound of 95% Confidence Interval for B
UB = Upper Bound of 95% Confidence Interval for B
b = Standardized Coefficient
* p < 0.05
HC = Healthy Control
MDD = Major Depressive Disorder
AAD = Any Anxiety Disorder
MDD + AAD = Major Depressive Disorder + Any Anxiety Disorder
Note: adjusted R2 Model with seasons and covariates = 0,337
Note: adjusted R2 Full model with seasons, covariates and interactions = 0,344
Winthorst et al. BMC Psychiatry 2011, 11:198
http://www.biomedcentral.com/1471-244X/11/198
Page 14 of 18
Figure 6 Inventory of Depressive Symptoms*, Melancholic symptoms#: mean score per season. * 30 Item self-report version of the
Inventory of Depressive Symptoms. # Melancholic symptoms: summation of the scores on the items loss of pleasure, lack of reactivity to usually
pleasurable stimuli, depressed mood, regularly worse in the morning, early morning awakening, psychomotor retardation or agitation, the
highest score of either anorexia or weight loss, and excessive or inappropriate guilt (score range 0 - 3, total score range 0 - 24). Total group (n =
1033), ▬ = Healthy Control (n = 446), ▲ = Any Anxiety disorder last month (n = 129), ■ = Major Depression last month (n = 121), ● = Major
Depression and Any Anxiety Disorder last month (n = 337). Values are mean scores. Error bars are Standard Errors of the mean.
Table 10 Melancholic symptoms of the IDS: regression model with groups and model with seasons
Main Effects B SE LB UB b p B SE LB UB b p
Intercept 1.56 0.15 1.28 1.84 < 0.01* 1.42 0.22 0.98 1.86 < 0.01*
HC (reference)
MDD 6.65 0.31 6.04 7.27 .71 < 0.01* 6.64 0.31 6.03 7.26 .70 < 0.01*
AAD 2.94 0.31 2.34 3.53 .32 < 0.01* 2.94 0.31 2.34 3.54 .31 < 0.01*
MDD + AAD -1.71 0.45 -2.58 -0.84 -.17 < 0.01* -1.71 0.45 -2.58 -0.83 -.17 < 0.01*
Summer (reference)
Autumn 0.19 0.26 -0.33 0.71 .02 0.47
Winter 0.20 0.28 -0.35 0.75 .02 0.48
Spring 0.18 0.28 -0.37 0.72 .02 0.52
IDS = Inventory of Depressive Symptoms
B = Unstandardized Coefficient
SE = standard error of B
LB = Lower Bound of 95% Confidence Interval for B
UB = Upper Bound of 95% Confidence Interval for B
b = Standardized Coefficient
* p < 0.05
HC = Healthy Control
MDD = Major Depressive Disorder
AAD = Any Anxiety Disorder
MDD + AAD = Major Depressive Disorder + Any Anxiety Disorder
Note: adjusted R2 Model with groups = 0,577
Note: adjusted R2 Model with seasons = 0,576
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was even minimized in the group of patients with MDD
possibly reflecting the fact that seasonality is usually
associated with minor depression, and that once the
threshold for a major depression has been passed, sea-
sonality is less influential [3,15,28]. According to the
results of this study it can not be ruled out that seasonal
mood changes are masked by use of medication or other
types of treatment [29,30].
The third finding was that both atypical and melan-
cholic symptoms were slightly more present in winter
(question 3). We had expected to find more atypical
depressive symptoms in winter, as Blacker [13] did in
his study among primary care patients. Literature on
seasonal affective disorder describes an atypical symp-
tom profile as a feature of seasonality [3,25,30-32]
though others did not find this [33]. An explanation
might be the probably low prevalence of seasonal affec-
tive disorders in this sample leading to a very small
effect on the mean scores of depression or anxiety
symptoms in this sample. Another explanation might be
an insufficient specificity of the atypical and melancholic
specifiers as defined by the DSM IV and used in this
article. Baumeister and Parker [34] pointed to the
overlap between the different subtyping models of
depression. Like Lamers et al. [35] they drew attention
tot the ongoing debate on the best criteria to delineate
melancholic depression from atypical depression and
other depressive conditions. There is considerable dis-
cussion whether in atypical depression rejection sensitiv-
ity should be included as a main criterion instead of
mood reactivity. Novick et al. [36] argued that anxiety is
even a more central feature to atypical depression than
mood reactivity. In addition to this, they reported that
atypical depression shows more co-morbidity with anxi-
ety symptoms than melancholic depression and more
likely occurs in younger women.
This study has several strengths: its large sample size
and its diagnostic procedures based on standardized
structured interviews. Bias caused by participants that
were left out of the analysis due to missing items is lim-
ited, because those participants represent no more than
1,5% (atypical symptoms) to 5,2% (melancholic symp-
toms) of the total patient population. The major limita-
tions of this study were its cross-sectional and
naturalistic design where seasonal effects may be
masked by treatment effects. Another limitation of this
Table 11 Melancholic symptoms of the IDS: regression model with groups, seasons, covariates and full model with
interactions
Main Effects B SE LB UB b p B SE LB UB b p
Intercept 1.62 0.25 1.12 2.12 < 0.01* 1.28 0.28 0.73 1.82 < 0.01*
HC (reference)
MDD 6.64 0.31 6.03 7.26 .70 < 0.01* 7.46 0.41 6.64 8.27 .79 < 0.01*
AAD 2.94 0.31 2.34 3.54 .31 < 0.01* 2.89 0.31 2.29 3.50 .32 < 0.01*
MDD + AAD -1.69 0.45 -2.56 -0.81 -.17 < 0.01* -1.63 0.45 -2.50 -0.75 -.16 < 0.01*
Summer (reference)
Autumn 0.20 0.26 -0.31 0.72 .02 0.44 0.23 0.26 -0.28 0.75 .02 0.38
Winter 0.20 0.28 -0.35 0.75 .02 0.47 0.74 0.36 0.03 1.44 .07 0.04*
Spring 0.20 0.28 -0.35 0.74 .02 0.48 0.22 0.28 -0.33 0.76 .02 0.43
Men (reference)
Women -0.34 0.20 -0.73 0.05 .04 0.09 0.03 0.26 -0.48 0.55 .003 0.90
Two way interactions
Winter & MDD -1.06 0.45 -1.95 -0.18 -.07 0.02*
Women & MDD -0.90 0.40 -1.69 -0.12 -.09 0.02*
IDS = Inventory of Depressive Symptoms
B = Unstandardized Coefficient
SE = standard error of B
LB = Lower Bound of 95% Confidence Interval for B
UB = Upper Bound of 95% Confidence Interval for B
b = Standardized Coefficient
* p < 0.05
HC = Healthy Control
MDD = Major Depressive Disorder
AAD = Any Anxiety Disorder
MDD + AAD = Major Depressive Disorder + Any Anxiety Disorder
Note: adjusted R2 Model with seasons and covariates = 0,577
Note: adjusted R2 Full model with seasons, covariates and interactions = 0,580
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study is the lack of specific instruments, such as the
SPAQ, to determine whether the previous course of ill-
ness had a seasonal pattern. Finally selection bias can
not be ruled out completely because data were not pri-
mary collected to answer this study assignment.
Conclusions
Seasonal differences in severity or type of depressive and
anxiety symptoms, as measured with a general screening
instrument and symptom questionnaires, were absent or
small in effectsize in a primary care population and in
patient populations with a major depressive disorder
and anxiety disorders. For the detection of individuals
with a seasonal pattern in depressive episodes more spe-
cific questionnaires and a longitudinal approach are
needed. These analyses will be forthcoming in our next
study on NESDA data.
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